The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKingfisher Regulatory News (KGF)

Share Price Information for Kingfisher (KGF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 248.90
Bid: 248.60
Ask: 248.70
Change: 1.90 (0.77%)
Spread: 0.10 (0.04%)
Open: 248.10
High: 249.40
Low: 247.30
Prev. Close: 247.00
KGF Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Changes

15 Apr 2024 07:00

RNS Number : 5287K
Kingfisher PLC
15 April 2024
 

KINGFISHER PLC

 

DIRECTORATE CHANGES

 

April 15, 2024

 

Kingfisher plc ('Kingfisher' or the 'Company') today announces that, after seven years as Chair of the Board, Andrew Cosslett has decided not to stand for re-election and will therefore step down from the Board of Directors at the conclusion of the Company's AGM on 20 June, 2024. Andrew will be succeeded by Claudia Arney, who has served as an Independent Non-Executive Director of Kingfisher since November 2018 and currently also chairs the Board's Remuneration Committee. Her appointment will take effect at the same time.

 

Catherine Bradley CBE, Senior Independent Director, said: "On behalf of the Board, I would like to thank Andy for his outstanding leadership and extensive contributions. He has overseen an important period of change for the Company, including the launch of the 'Powered by Kingfisher' strategy, laying the foundation for the Company's future success. We wish him the very best for the future.

 

I would also like to congratulate Claudia on her appointment as Chair of the Board. After careful consideration and a thorough process, the Board is confident that Claudia is an excellent choice. During her time as a Non-Executive Director, Claudia has demonstrated that she has a breadth of knowledge and experience which, together with her leadership and judgment, will be crucial as we drive our strategy forwards."

 

Andrew Cosslett said: "It has been a privilege to serve as Kingfisher's Chair over the last seven years. During this time we have changed and strengthened our leadership team, put in place a more effective business strategy, managed the pandemic and worked hard to further the Company's reputation as a champion for responsible business. I am proud to have been able to play my part and am delighted to now pass the baton onto Claudia whose skills and judgement will be key in ensuring the good progress continues. I leave the company with great confidence in its future."

 

Claudia Arney said: "Kingfisher is a fantastic business, which maintains a sharp focus on striving to better serve its customers while delivering long-term value for all its stakeholders. I look forward to continuing to support our great management team in our mission of making home improvement accessible to everyone. Since joining the Board in 2018, I have learned a great deal about the complexities and nuance of our business and retail banners, and about our 80,000 passionate and committed colleagues in many countries. It is an honour to take on the role."

 

On appointment, Claudia will step down as Chair of the Remuneration Committee and will be succeeded by Rakhi Goss-Custard from the conclusion of the 2024 AGM. Rakhi has served as a Non-Executive Director of Kingfisher since February 2016, including as a member of the Remuneration Committee since March 2018, and has extensive knowledge of Kingfisher's business. She currently also chairs the Remuneration Committee of Trainline plc, and has previously served on the Remuneration Committee of Rightmove plc. The Board has agreed that in view of Rakhi's experience, she is very well positioned to take on the role, and to ensure effective continuity. Recognising Rakhi's existing length of service on the Board, a succession process is also ongoing to identify a new Remuneration Committee Chair to take on the role over the longer-term. 

 

This announcement is made in accordance with Listing Rule 9.6.11.

 

There are no further matters to be updated in respect of the directorate changes under Listing Rule 9.6.13R.

 

Enquiries:

Contacts:

Tel:

Email:

Company Secretary

+44 (0) 7768 806 248

secretariat@kingfisher.com

Investor Relations

+44 (0) 20 7644 1082

investorenquiries@kingfisher.com

Media Relations

+44 (0) 20 7644 1030

corpcomms@kingfisher.com

Teneo

+44 (0) 20 7420 3184

Kfteam@teneo.com

 

About Claudia Arney:

 

Claudia joined the Board as a Non-Executive Director in November 2018 and is currently chair of the Remuneration Committee.

 

Claudia brings a wealth of experience of business transformation and building digital capabilities to the Board having previously held non-executive roles, including interim chair of the Premier League, senior independent director of Telecity Group plc, chair of the remuneration committee at Halfords plc, non-executive director at Ocado Group plc, and governance committee chair at Aviva plc. Claudia began her career at McKinsey & Company, before holding roles at Pearson, the Financial Times, Goldman Sachs, and HM Treasury. She was also group managing director, digital at EMAP.

 

Claudia is currently Chair of the Board of Deliveroo plc and, until she steps down in May 2024, non-executive director and remuneration committee chair at Derwent London plc. She also serves as a member of the Panel on Takeovers and Mergers and is the lead non-executive Board member for the Department for Digital, Culture, Media and Sport. 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOASFMFDLELSELL
Date   Source Headline
29th Apr 20247:00 amRNSTransaction in Own Shares
26th Apr 20245:05 pmRNSDirector/PDMR Shareholding
26th Apr 20245:00 pmRNSDirector/PDMR Shareholding
26th Apr 20247:00 amRNSTransaction in Own Shares
25th Apr 20244:00 pmRNSDirector/PDMR Shareholding
25th Apr 20247:00 amRNSTransaction in Own Shares
24th Apr 20247:00 amRNSTransaction in Own Shares
23rd Apr 202411:00 amRNSDirector/PDMR Shareholding
23rd Apr 20247:00 amRNSTransaction in Own Shares
22nd Apr 20247:00 amRNSTransaction in Own Shares
19th Apr 20247:00 amRNSTransaction in Own Shares
18th Apr 20247:00 amRNSTransaction in Own Shares
17th Apr 202411:00 amRNSDirector/PDMR Shareholding
17th Apr 20247:00 amRNSTransaction in Own Shares
16th Apr 20247:00 amRNSTransaction in Own Shares
15th Apr 202412:03 pmRNSAnnual Financial Report & Notice of AGM
15th Apr 20247:00 amRNSDirectorate Changes
15th Apr 20247:00 amRNSTransaction in Own Shares
12th Apr 20247:00 amRNSTransaction in Own Shares
11th Apr 20247:00 amRNSTransaction in Own Shares
10th Apr 20247:00 amRNSTransaction in Own Shares
9th Apr 20247:00 amRNSTransaction in Own Shares
8th Apr 20247:00 amRNSTransaction in Own Shares
5th Apr 20247:00 amRNSTransaction in Own Shares
4th Apr 20247:00 amRNSTransaction in Own Shares
3rd Apr 20247:00 amRNSTransaction in Own Shares
2nd Apr 20243:30 pmRNSTotal Voting Rights
2nd Apr 20247:00 amRNSTransaction in Own Shares
28th Mar 20247:00 amRNSTransaction in Own Shares
27th Mar 20247:30 amRNSShare Repurchase Programme - Second Tranche
25th Mar 20247:00 amRNSFinal Results (Part 2 of 2)
25th Mar 20247:00 amRNSFinal Results (Part 1 of 2)
7th Mar 20249:00 amRNSDirector Declaration
1st Mar 202411:00 amRNSTotal Voting Rights
22nd Feb 20244:15 pmRNSHolding(s) in Company
9th Feb 202411:00 amRNSAppointment of Joint-Brokers
5th Feb 20245:15 pmRNSHolding(s) in Company
1st Feb 202412:00 pmRNSTotal Voting Rights
23rd Jan 20244:45 pmRNSDirector/PDMR Shareholding
12th Jan 202410:00 amRNSHolding(s) in Company
11th Jan 20247:05 amRNSFirst Tranche of Share Repurchase Programme
11th Jan 20247:00 amRNSTransaction in Own Shares
10th Jan 202410:15 amRNSTotal Voting Rights
10th Jan 20247:00 amRNSTransaction in Own Shares
9th Jan 20247:00 amRNSTransaction in Own Shares
8th Jan 20247:00 amRNSTransaction in Own Shares
5th Jan 20247:00 amRNSTransaction in Own Shares
4th Jan 20247:00 amRNSTransaction in Own Shares
3rd Jan 20247:00 amRNSTransaction in Own Shares
2nd Jan 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.